(Q37978200)

26 August 2017

Preschool children with obsessive-compulsive disorder and fluoxetine treatment (English)

1 reference

obsessive-compulsive disorder

26 August 2017

0 references

1 reference

Eyup Sabri Ercan

1

1 reference

PubMed ID

22271063

26 August 2017

Rasiha Kandulu

series ordinal

2

1 reference

PubMed ID

22271063

26 August 2017

Ulku Akyol Ardic

series ordinal

3

1 reference

26 August 2017

22 January 2012

1 reference

European Child & Adolescent Psychiatry

26 August 2017

1 reference

26 August 2017

21

1 reference

26 August 2017

3

1 reference

26 August 2017

169-172

1 reference

https://scigraph.springernature.com/pub.10.1007/s00787-012-0244-2

26 August 2017

0 references

cites work

Psychopharmacological treatment for very young children: contexts and guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS00787-012-0244-2

Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-012-0244-2

Children with very early onset obsessive-compulsive disorder: clinical features and treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-012-0244-2

Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-012-0244-2

Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-012-0244-2

Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-012-0244-2

Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-012-0244-2

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00787-012-0244-2

Fluoxetine treatment in a 2.5-year-old girl

21 January 2018

1 reference

12 December 2020

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

12 December 2020

Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience

1 reference

12 December 2020

Fluoxetine in posttraumatic eating disorder in two-year-old twins

1 reference

12 December 2020

10.1007/S00787-012-0244-2

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22271063